ChemSpider 2D Image | (1E,3R,4R)-3,6-Diamino-4-hydroxy-N-{(1E,4Z,6Z,7E,9S,10E,12S,13E,15S)-2,5,8,11,14-pentahydroxy-6-({[hydroxy(imino)methyl]amino}methylene)-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl]
-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl}hexanimidic acid (non-preferred name) | C25H43N13O10

(1E,3R,4R)-3,6-Diamino-4-hydroxy-N-{(1E,4Z,6Z,7E,9S,10E,12S,13E,15S)-2,5,8,11,14-pentahydroxy-6-({[hydroxy(imino)methyl]amino}methylene)-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl] -1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl}hexanimidic acid (non-preferred name)

  • Molecular FormulaC25H43N13O10
  • Average mass685.690 Da
  • Monoisotopic mass685.325562 Da
  • ChemSpider ID34982104
  • defined stereocentres - 7 of 7 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(1E,3R,4R)-3,6-Diamino-4-hydroxy-N-{(1E,4Z,6Z,7E,9S,10E,12S,13E,15S)-2,5,8,11,14-pentahydroxy-6-({[hydroxy(imino)methyl]amino}methylen)-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl]- 1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl}hexanimidsäure (non-preferred name) [German] [ACD/IUPAC Name]
(1E,3R,4R)-3,6-Diamino-4-hydroxy-N-{(1E,4Z,6Z,7E,9S,10E,12S,13E,15S)-2,5,8,11,14-pentahydroxy-6-({[hydroxy(imino)methyl]amino}methylene)-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl] -1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl}hexanimidic acid (non-preferred name) [ACD/IUPAC Name]
Acide (1E,3R,4R)-3,6-diamino-4-hydroxy-N-{(1E,4Z,6Z,7E,9S,10E,12S,13E,15S)-2,5,8,11,14-pentahydroxy-6-({[hydroxy(imino)méthyl]amino}méthylène)-9,12-bis(hydroxyméthyl)-3-[(4R)-2-iminohexahydro-4-pyrimi dinyl]-1,4,7,10,13-pentaazacyclohexadéca-1,4,7,10,13-pentaén-15-yl}hexanimidique (non-preferred name) [French] [ACD/IUPAC Name]
(3R,4R)-3,6-diamino-4-hydroxy-N-[(3S,6Z,9S,12S,15S)-2,5,8,11,14-pentahydroxy-6-[(C-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4R)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaaz
(3R,4R)-3,6-diamino-4-hydroxy-N-[(3S,6Z,9S,12S,15S)-2,5,8,11,14-pentahydroxy-6-{[(C-hydroxycarbonimidoyl)amino]methylidene}-9,12-bis(hydroxymethyl)-3-[(4R)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-penta
33103-22-9 [RN]
acyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
azacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
Enviomicina
Enviomicina; Enviomycin; Enviomycine; Enviomycinum; Tuberactinomycin N
More...

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.8±0.1 g/cm3
Boiling Point: 1156.3±75.0 °C at 760 mmHg
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Enthalpy of Vaporization: 192.9±6.0 kJ/mol
Flash Point: 653.1±37.1 °C
Index of Refraction: 1.762
Molar Refractivity: 156.3±0.5 cm3
#H bond acceptors: 23
#H bond donors: 19
#Freely Rotating Bonds: 11
#Rule of 5 Violations: 3
ACD/LogP: -8.03
ACD/LogD (pH 5.5): -13.09
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.00
ACD/LogD (pH 7.4): -10.78
ACD/BCF (pH 7.4): 1.00
ACD/KOC (pH 7.4): 1.00
Polar Surface Area: 412 Å2
Polarizability: 62.0±0.5 10-24cm3
Surface Tension: 91.8±7.0 dyne/cm
Molar Volume: 379.0±7.0 cm3

Click to predict properties on the Chemicalize site






Advertisement